SmartGateVC — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Amaros builds AmarosEngine, a precision intelligence platform that integrates ophthalmology clinics' EHR, practice management, and imaging systems to unify ophthalmic data and generate real-world evidence and insights.
AI & Machine LearningBiotechDigital Health
Ben Toker(President & Co-Founder)in
Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in
Co-investorsArtesianASDF VenturesBlackbird VenturesDivergent CapitalEmpath VenturesIrregular Expressions+5 more
Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtechMedical DevicesMountain View, US
Ryan Dittamore(CEO)in
Co-investorsAngel Physicians FundBeresford VenturesBlack Mountain VentuesCreative Destruction Lab (CDL)Samsung NextShanda Group+3 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Ladder Bio (formerly ThirdLaw Molecular)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.











